Log in or Sign up for Free to view tailored content for your specialty!
Lung Cancer News
FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy
The FDA approved atezolizumab and hyaluronidase-tqjs for subcutaneous injection.
Ivonescimab extends PFS vs. pembrolizumab in advanced NSCLC, may be ‘a new standard’
Ivonescimab significantly improved PFS compared with pembrolizumab as first-line treatment of PD-L1-positive advanced non-small cell lung cancer, according to results of the HARMONi-2 trial.
Perioperative nivolumab improves outcomes in resectable NSCLC
Immunotherapy before and after surgery significantly improved EFS compared with neoadjuvant immunotherapy only for patients with resectable non-small cell lung cancer, according to a comparison of results from two randomized phase 3 trials.
Log in or Sign up for Free to view tailored content for your specialty!
Despite progress, barriers to lung cancer biomarker testing persist
Acceptance and utilization of lung cancer biomarker testing has increased in the past 6 years, but key barriers persist, according to survey results.
Q&A: Managing patients with central airway obstruction
Patients with central airway obstruction are often treated by multiple clinicians from different specialties, leading to varied management of the patients, according to a press release.
Atezolizumab regimen ‘merits further study’ for unresectable NSCLC
Neoadjuvant atezolizumab prior to chemoradiation therapy exhibited promising activity for patients with unresectable stage III non-small cell lung cancer, according to results of a nonrandomized phase 2 study.
Phase 3 trials of pembrolizumab for lung cancer, skin cancer halted due to lack of efficacy
Two randomized phase 3 trials of pembrolizumab — one in lung cancer and one in skin cancer — have been discontinued due to lack of efficacy, according to the agent’s manufacturer.
Individualized neoantigen therapy could be ‘huge leap’ toward personalized medicine
A novel therapeutic approach stimulated new and existing T-cell responses among patients with melanoma or non-small cell lung cancer, according to results of a phase 1 trial.
‘Popularity paradox’: Evidence lacking to support lung cancer screening for never-smokers
Current evidence does not support lung cancer screening for never-smokers or former light smokers with a family history of lung cancer, according to a commentary in Journal of Thoracic Oncology.
42% of nonsmokers have one or more solid lung nodules
A lung nodule sized 30 mm3 or greater was found in 42% of adults in Northern Europe who reported either never smoking or former smoking, according to results published in Radiology.
-
Headline News
Eating more meat may increase risk for developing type 2 diabetes
September 12, 20242 min read -
Headline News
Prevalence of atrial fibrillation in U.S. adults much higher than previous estimates
September 11, 20242 min read -
Headline News
Food insecurity, socioeconomic development influence global prevalence of MASLD
September 11, 20242 min read
-
Headline News
Eating more meat may increase risk for developing type 2 diabetes
September 12, 20242 min read -
Headline News
Prevalence of atrial fibrillation in U.S. adults much higher than previous estimates
September 11, 20242 min read -
Headline News
Food insecurity, socioeconomic development influence global prevalence of MASLD
September 11, 20242 min read